deferiprone has been researched along with Ischemia in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Thapa, K | 1 |
Singh, TG | 1 |
Kaur, A | 1 |
Reuter, DG | 1 |
Tacker, WA | 1 |
Babbs, CF | 1 |
Badylak, SF | 1 |
Voorhees, WD | 1 |
Konrad, PE | 1 |
1 review available for deferiprone and Ischemia
Article | Year |
---|---|
Targeting ferroptosis in ischemia/reperfusion renal injury.
Topics: Deferasirox; Deferiprone; Ferroptosis; Humans; Iron; Iron Chelating Agents; Ischemia; Kidney; Pharma | 2022 |
1 other study available for deferiprone and Ischemia
Article | Year |
---|---|
Preliminary results of deferoxamine and L1 treatment of spinal cord ischemia.
Topics: Animals; Deferiprone; Deferoxamine; Dogs; Iron Chelating Agents; Ischemia; Pyridones; Reperfusion In | 1995 |